1. Companies
  2. Modalis Therapeutics
  3. Team

  4. Team

Modalis Therapeutics

Modalis Therapeutics

Emerging biotech company that develops therapeutics using CRISPR based technology.
Launch date
Employees
11-50 people
Market cap
$30.2m
Enterprise valuation
$22m (Public information from Sep 2024)
Cambridge Massachusetts (HQ), Tokyo Japan (founding location)
https://www.modalistx.com/jp/
https://twitter.com/modalistxhttps://www.linkedin.com/company/edigene-inc
Authorizing premium user...